Curetis' Series A - III Round

Curetis raised a round of funding on October 26, 2011.

Curetis (AMS:CURE) is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast, and cost-effective products for diagnosing severe infectious diseases. T…

Articles about Curetis' Series A - III Round: